Loading institutional data...
Loading institutional data...
Held by 439 of 5,944 reporting institutions (96th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $7.1M 100.0% | $10.8M 100.0% | $12.0M 100.0% | $13.1M 100.0% | $8.2M 100.0% |
| Cost of Revenue | $5.0M 70.9% | $5.1M 47.2% | $2.8M 23.3% | $2.9M 21.9% | $1.6M 19.8% |
| Gross Profit | $2.1M 29.1% | $5.7M 52.8% | $9.2M 76.7% | $10.2M 78.1% | $6.6M 80.2% |
| Research & Development | $61.3M 865.5% | $49.8M 461.1% | $52.8M 439.4% | $60.0M 457.6% | $26.9M 328.6% |
| Selling, General & Admin | $25.4M 358.1% | $24.5M 226.7% | $27.7M 231.0% | $54.0M 412.0% | $11.3M 137.9% |
| Total Operating Expenses | $86.7M 1223.5% | $74.2M 687.7% | $81.5M 678.7% | $119.3M 910.6% | $40.7M 496.6% |
| Operating Income | -$84.7M -1194.4% | -$68.5M -634.9% | -$72.3M -602.1% | -$109.1M -832.5% | -$34.1M -416.4% |
| Interest Expense | $0 0.0% | $3.3M 30.2% | $5.8M 48.1% | $5.3M 40.3% | $2.5M 30.1% |
| Interest & Investment Income | $16.6M 233.6% | $5.1M 47.4% | $5.1M 42.3% | $2.4M 18.6% | $10K 0.1% |
| Other Income (Expense), net | -$131.6M -1856.0% | -$132.5M -1227.8% | -$2.8M -23.4% | $37.6M 286.7% | -$4.1M -50.2% |
| Pretax Income | -$216.2M -3050.4% | -$201.0M -1862.7% | -$75.1M -625.5% | -$71.5M -545.9% | -$38.2M -466.6% |
| Income Tax Expense | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% |
| Net Income | -$216.2M -3050.4% | -$201.0M -1862.7% | -$75.1M -625.5% | -$71.5M -545.9% | -$38.2M -466.6% |
| Per Share | |||||
| EPS (Basic) | $-0.70 | $-1.09 | $-0.57 | $-0.70 | $-1.64 |
| EPS (Diluted) | $-0.70 | $-1.09 | $-0.57 | $-0.70 | $-1.64 |
| Weighted Avg Shares (Basic) | 309.8M | 184.7M | 132.0M | 102.3M | 23.3M |
| Weighted Avg Shares (Diluted) | 309.8M | 184.7M | 132.0M | 102.3M | 23.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
3/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$77M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 5 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -40%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 5 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $45M covers all $32M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2022-09-30 (10-Q).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Interest last disclosed in FY2024 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
No current price collected.
No standout strengths flagged.
Where each multiple sits in its own 5-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cost of Revenue | 19.8 | 21.9 | 23.3 | 47.2 | 70.9 |
| Gross Profit | 80.2 | 78.1 | 76.7 | 52.8 | 29.1 |
| R&D | 328.6 | 457.6 | 439.4 | 461.1 | 865.5 |
| SG&A | 137.9 | 412.0 | 231.0 | 226.7 | 358.1 |
| Operating Income | -416.4 | -832.5 | -602.1 | -634.9 | -1194.4 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -466.6 | -545.9 | -625.5 | -1862.7 | -3050.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on RGTI: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position